TEDD Annual Meeting

During this year’s TEDD Annual Meeting, we will explore the clinical applications of advanced cell culture models and highlight their potential in revolutionizing biomedical research and patient care. We will delve into their use in disease modelling, drug screening, personalized medicine, regenerative medicine, and other emerging areas. By examining the current state of the field and discussing recent advancements, we aim to shed light on the transformative potential of these models in clinical practice and pave the way for future developments in this exciting field.

Register until September 1, 2023.

Program

Prof Javad Nazarian
University Childrens‘ Hospital Zurich Oncology Department, Switzerland
Title: From biopsy to cure: a challenge for precision oncology

Prof Benjamin Gantenbein
University of Bern, Medical Faculty, Department for BioMedical Research, Switzerland
Title: What regeneration in orthopaedics might bring to an increasingly elderly society

Bianca Fischli (Team of Prof Michael Raghunath)
TEDD Competence Centre, Zurich University of Applied Sciences (ZHAW), Switzerland
Title: Vascular pattern making using sound induced morphogenesis – experience with the first commercial CymatiX instrument

Dr. Priyanka Dutta-Passecker
Healiva SA, Switzerland
Title: Unleashing the Potential of Healiva Cell Therapy Models in Advancing Clinical Applications

Dr. Arno Amann
Department of Haematology and Oncology, Medical University of Innsbruck, Austria
Title: Role of Functional Drug Testing in Precision Oncology

Dr Markus Mühlemann
Kugelmeiers, Switzerland
Title: The role of standardized spheroids in pancreatic islet transplantation

Dr Deana Mohr
MUVON Therapeutics, Switzerland
Title: MUVON from bench to bedside

Dr Jakob Pyszkowski
Optics11 Life, Amsterdam, Netherlands
Title: Stimulation through innovation: A new way to monitor engineered muscle tissues for personalized clinical advances